Tiedemann Trust’s Pfizer PFE Stock Holding History

Tiedemann Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$461K	Buy	13,797 +395	+3%	+$12.6K	0.09%	46
2016 Q1	$377K	Buy	13,402 +1,054	+9%	+$30.1K	0.06%	55
2015 Q4	$378K	Sell	12,348 -2,292	-16%	-$72.1K	0.05%	58
2015 Q3	$436K	Buy	14,640 +1,976	+16%	+$63.4K	0.04%	42
2015 Q2	$403K	Buy	12,664 +316	+3%	+$10.3K	0.03%	55
2015 Q1	$408K	Sell	12,348 -138	-1%	-$4.39K	0.04%	45
2014 Q4	$369K	Sell	12,486 -3,162	-20%	-$90.7K	0.03%	54
2014 Q3	$438K	Hold	15,648	–	–	0.04%	65
2014 Q2	$440K	Hold	15,648	–	–	0.04%	65
2014 Q1	$476	Buy	15,648 +4,245	+37%	+$127K	0.05%	67
2013 Q4	$331K	Sell	11,403 -6,298	-36%	-$183K	0.05%	67
2013 Q3	$482K	Sell	17,701 -26,350	-60%	-$717K	0.08%	48
2013 Q2	$1.17M	Buy	+44,051	New	+$1.22M	0.2%	39

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tiedemann Trust's PFE Position: Q2 2016 in Review

Tiedemann Trust increased its Pfizer (PFE) stake by 2.9% in Q2 2016, buying an estimated $12.6K and bringing the position to 13,797 shares worth $461K. The position accounts for 0.09% of the portfolio, ranked #46.

Tiedemann Trust first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.17M in Q2 2013. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Tiedemann Trust held 13,797 shares of Pfizer worth $461K as of Q2 2016.
Tiedemann Trust bought 395 Pfizer shares in Q2 2016, an estimated $12.6K.
Pfizer made up 0.09% of Tiedemann Trust's portfolio in Q2 2016, its #46 holding.
Tiedemann Trust first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
Tiedemann Trust's Pfizer position peaked at $1.17M in Q2 2013.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Tiedemann Trust's 13F filing for Q2 2016, filed 12 Aug 2016.